Hope so, but I don't believe financing or uplisting is coming this month. We have been talking about this for years and always led to believe we were almost there. That's just the reality. We need to enroll the trial. If we have great results and approval, we'll have a stack of legitimate financing options on Nader's desk, and then we can realistically uplist to NYSE. IMO, this is BY FAR the most likely order of events.